Evidence map›Paper›PMID 28692384›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Advancing the Use of Emergency Department Syndromic Surveillance Data, New York City, 2012-2016.

Ramona Lall, Jasmine Abdelnabi, Stephanie Ngai, Hilary B Parton, Kelly Saunders, Jessica Sell, Amanda Wahnich, Don Weiss, Robert W Mathes

Open access · bronzeAbstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Early Detection of SARS-CoV-2 Epidemic Waves: Lessons from the Syndromic Surveillance in Lombardy, Italy.International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Perspective on Improving Environmental Monitoring of Biothreats.Frontiers in bioengineering and biotechnology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ramona Lall1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Jasmine Abdelnabi1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Stephanie Ngai1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Hilary B Parton1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Kelly Saunders1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Jessica Sell1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Amanda Wahnich1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Don Weiss1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Robert W Mathes1 Bureau of Communicable Diseases, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
New York City Department of Health and Mental Hygiene · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of syndromic surveillance has expanded from its initial purpose of bioterrorism detection. We present 6 use cases from New York City that demonstrate the value of syndromic surveillance for public health response and decision making across a broad range of health outcomes: synthetic cannabinoid drug use, heat-related illness, suspected meningococcal disease, medical needs after severe weather, asthma exacerbation after a building collapse, and Ebola-like illness in travelers returning from West Africa. MATERIALS AND

methodsThe New York City syndromic surveillance system receives data on patient visits from all emergency departments (EDs) in the city. The data are used to assign syndrome categories based on the chief complaint and discharge diagnosis, and analytic methods are used to monitor geographic and temporal trends and detect clusters.

resultsFor all 6 use cases, syndromic surveillance using ED data provided actionable information. Syndromic surveillance helped detect a rise in synthetic cannabinoid-related ED visits, prompting a public health investigation and action. Surveillance of heat-related illness indicated increasing health effects of severe weather and led to more urgent public health messaging. Surveillance of meningitis-related ED visits helped identify unreported cases of culture-negative meningococcal disease. Syndromic surveillance also proved useful for assessing a surge of methadone-related ED visits after Superstorm Sandy, provided reassurance of no localized increases in asthma after a building collapse, and augmented traditional disease reporting during the West African Ebola outbreak. PRACTICE IMPLICATIONS: Sharing syndromic surveillance use cases can foster new ideas and build capacity for public health preparedness and response.

Indexed as

AsthmaCommunicable Diseases, EmergingDisease OutbreaksEmergency Service, HospitalHeat StrokeHumansMarijuana AbuseNew York CityPopulation SurveillancePublic Health Informaticsemergency departmentsyndromic surveillanceuse cases

Identifiers

PMID28692384
PMCPMC5676519
OpenAlexW2738850909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.